NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans

AI Briefing

• – NorthStrive Biosciences files patent application for EL-22 targeting muscle preservation
• – EL-22 aims to prevent muscle loss and atrophy in humans
• – Company seeks to develop new treatment for muscle-related disorders and injuries